The company
Aldeyra Therapeutics, Inc.
ALDX · Nasdaq
ALDX stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 32 weeks. It is 58.4% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 32
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $1.0M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 102 (-16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Todd C. BradyPresident and CEO | bought | 250,000at $1.67 | 3 Jun 2026filed 5 Jun 2026 |
| Richard DouglasDirector | bought | 70,000at $1.40 | 19 Mar 2026filed 20 Mar 2026 |
| Michael AlfieriPrincipal Financial Officer | bought | 5,000at $1.42 | 18 Mar 2026filed 19 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLCunchanged · filed 14 Aug 2026 | 5,475,516$11.7M | 00.0% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 3,751,558$8.0M | +921,683+32.6% |
| KINGDON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026 | 2,652,315$5.6M | +500,000+23.2% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,361,796$5.0M | -1,946−0.1% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 1,940,338$4.1M | +536,348+38.2% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 1,506,974$3.2M | +1,377,281+1062.0% |
| 683 Capital Management, LLCreduced · filed 14 Aug 2026 | 1,450,000$3.1M | -50,000−3.3% |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 1,375,115$2.9M | +406,224+41.9% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 1,257,243$2.7M | -2,506,644−66.6% |
| Qube Research & Technologies Ltdadded · filed 14 Aug 2026 | 1,128,803$2.4M | +1,041,725+1196.3% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.